Cizzle Biotechnology Holdings PLC의 주요 재무제표는 무엇인가요?
CIZZF의 주요 재무 비율은 무엇인가요?
Cizzle Biotechnology Holdings PLC의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Cizzle Biotechnology Holdings PLC은 수익성이 있나요?
Cizzle Biotechnology Holdings PLC에 부채가 있나요?
Cizzle Biotechnology Holdings PLC의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
EPS(TTM)
--
배당수익률
--
시가총액
--
CIZZF란 무엇인가요?
Cizzle Biotechnology Holdings Plc is a holding company, which engages in detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. The firm is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. The company is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.